Desvenlafaxine 50 and 100 mg/d versus placebo for the treatment of major depressive disorder: a phase 4, randomized controlled trial.
Saved in:
| Title: | Desvenlafaxine 50 and 100 mg/d versus placebo for the treatment of major depressive disorder: a phase 4, randomized controlled trial. |
|---|---|
| Authors: | Clayton AH; University of Virginia Health System, PO Box 800623, Charlottesville, VA 22908-0623 ahc8v@virginia.edu., Tourian KA, Focht K, Hwang E, Cheng RF, Thase ME |
| Source: | The Journal of clinical psychiatry [J Clin Psychiatry] 2015 May; Vol. 76 (5), pp. 562-9. |
| Publication Type: | Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Physicians Postgraduate Press Country of Publication: United States NLM ID: 7801243 Publication Model: Print Cited Medium: Internet ISSN: 1555-2101 (Electronic) Linking ISSN: 01606689 NLM ISO Abbreviation: J Clin Psychiatry Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 25375652 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Desvenlafaxine 50 and 100 mg/d versus placebo for the treatment of major depressive disorder: a phase 4, randomized controlled trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Clayton+AH%22">Clayton AH</searchLink>; University of Virginia Health System, PO Box 800623, Charlottesville, VA 22908-0623 ahc8v@virginia.edu.<br /><searchLink fieldCode="AU" term="%22Tourian+KA%22">Tourian KA</searchLink><br /><searchLink fieldCode="AU" term="%22Focht+K%22">Focht K</searchLink><br /><searchLink fieldCode="AU" term="%22Hwang+E%22">Hwang E</searchLink><br /><searchLink fieldCode="AU" term="%22Cheng+RF%22">Cheng RF</searchLink><br /><searchLink fieldCode="AU" term="%22Thase+ME%22">Thase ME</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227801243%22">The Journal of clinical psychiatry</searchLink> [J Clin Psychiatry] 2015 May; Vol. 76 (5), pp. 562-9. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Physicians+Postgraduate+Press%22">Physicians Postgraduate Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7801243 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1555-2101 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201606689%22">01606689 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Psychiatry <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=25375652 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.4088/JCP.13m08978 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 562 Titles: – TitleFull: Desvenlafaxine 50 and 100 mg/d versus placebo for the treatment of major depressive disorder: a phase 4, randomized controlled trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Clayton AH – PersonEntity: Name: NameFull: Tourian KA – PersonEntity: Name: NameFull: Focht K – PersonEntity: Name: NameFull: Hwang E – PersonEntity: Name: NameFull: Cheng RF – PersonEntity: Name: NameFull: Thase ME IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2015 May Type: published Y: 2015 Identifiers: – Type: issn-electronic Value: 1555-2101 Numbering: – Type: volume Value: 76 – Type: issue Value: 5 Titles: – TitleFull: The Journal of clinical psychiatry Type: main |
| ResultId | 1 |
